Medico Intercontinental Ltd Quarterly Results
Q3 FY25-26 Results Summary
Revenue
The revenue stands at ₹19.85 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 2.70 per cent from ₹20.40 crore. This corresponds to a year-on-year *(YoY) growth of 7.70 per cent.
Operating Profit
Operating Profit stands at ₹1.59 crore, reflecting a quarter-on-quarter *(QoQ) increase of 280.68 per cent from ₹-0.88 crore. This corresponds to a year-on-year *(YoY) decline of 16.32 per cent.
PBDT
PBDT stands at ₹0.05 crore, reflecting a quarter-on-quarter *(QoQ) increase of 102.12 per cent from ₹-2.36 crore. This corresponds to a year-on-year *(YoY) decline of 97.27 per cent.
Profit Before Tax
Profit Before Tax stands at ₹-1.38 crore, reflecting a quarter-on-quarter *(QoQ) increase of 67.98 per cent from ₹-4.31 crore. This corresponds to a year-on-year *(YoY) decline of 186.25 per cent.
Net Profit
Net Profit stands at ₹-1.66 crore, reflecting a quarter-on-quarter *(QoQ) increase of 63.19 per cent from ₹-4.51 crore. This represents a 241.88 per cent year-on-year *(YoY) decline for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Market News
Medico Intercontinental Ltd Earnings
- YOY
- QOQ
Medico Intercontinental Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Medico Intercontinental Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Medico Intercontinental Ltd Financial Reports
Medico Intercontinental Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Medico Intercon. | 3.13% | 0.88% | -6.47% | 6.82% | -14.97% | -18.44% |
| Vasundhara Rasy. | 5.44% | -2.34% | -19.07% | -37.51% | -41.25% | -54.46% |
| Roopa Industries | 0.00% | 2.30% | -8.45% | 0.05% | -17.84% | -20.76% |
| Welcure Drugs | -3.70% | -10.34% | -21.21% | -38.10% | -63.38% | -69.77% |
| ANG Lifesciences | 3.47% | -1.50% | -5.31% | -17.95% | -36.00% | -24.00% |
| Ishita Drugs | -1.24% | 9.62% | 17.90% | 11.10% | 5.99% | 6.47% |
| Venmax Drugs | 5.35% | 5.35% | -4.30% | -7.82% | 2.18% | 5.74% |
Company Info
Company Information
Managing Director : Samir Shah
Addtnl Non-Executive Director : Amar Jaiswal
Addtnl Non-Executive Director : Mitul Shah
Addtnl Non-Executive Director : Tanvi Shah
Addtnl Independent Director : Dinesh Shah